tirzepatide fda label approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly seeks FDA approval

The company expects to complete its Phase 3 trial program in late 2026 or early 2027, which would enable an FDA submission

Uses U-100 insulin syringe standard (100 units = 1mL) Formula: Units = (Dose mg Concentration mg/mL) 100 Supports both mg/mL and mg/0.5mL label formats Sources: FDA Mounjaro & Zepbound prescribing information Confusing mg/mL with mg/0.5mL: If your vial says "5mg/0.5mL", that's actually 10mg/mL

Note: GHK-Cu (Copper Tripeptide) is an experimental biological peptide and as such ingestion or use of this product is for experimental purposes ONLY

Using our supplement testing methodology, our team of experts combed through dozens of products to make sure youre getting the best fat burner for active women

Each compound has a distinct profile of benefits, drawbacks, and clinical data depth